This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Calliditas Therapeutics Suisse Sa, University of Southampton. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024
Title: Kirsty Ford - Innovator in Cancer Treatment
Introduction
Kirsty Ford is a notable inventor based in Weymouth, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on enhancing the effectiveness of immunotherapy, particularly in restoring responsiveness to various cancer treatments.
Latest Patents
Kirsty Ford holds a patent for the "Use of NOX inhibitors for treatment of cancer." This invention relates to compounds, methods, compositions, and uses that can restore responsiveness to immunotherapy, specifically immune checkpoint inhibitors or anti-cancer vaccines, as well as anti-angiogenesis treatments. His patent represents a crucial advancement in the ongoing battle against cancer.
Career Highlights
Throughout his career, Kirsty has worked with prominent organizations, including Calliditas Therapeutics Suisse SA and the University of Southampton. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kirsty has collaborated with notable colleagues such as Christopher Hanley and Gareth Thomas. These partnerships have further enriched his research and development efforts in cancer treatment.
Conclusion
Kirsty Ford's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to pave the way for advancements in immunotherapy and cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile